← Search

Government-Academic Partnerships in Randomized Evaluations: The Case of Inappropriate Prescribing

Adam Sacarny¹; David Yokum²; Shantanu Agrawal³

¹ Department of Health Policy and Management, Mailman School of Public Health, Columbia University, 722 W 168 Street, 4th Floor, New York, NY 10032, National Bureau of Economic Research, and Abdul Latif Jameel Poverty Action Lab (J-PAL) (e-mail: ) · ² Office of Evaluation Sciences, US General Services Administration (previous), 1350 Pennsylvania Avenue, NW, Washington, DC 20004 and The Lab @ DC, Government of the District of Columbia (current), (e-mail: ) · ³ Center for Program Integrity, Centers for Medicare and Medicaid Services, US Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244 (e-mail: )

There is growing evidence that inappropriate prescribing is harming patients and raising costs in the US health care system. Through a partnership between the federal government and academics, we seek to develop evidence on reducing this prescribing. We conduct several randomized letter interventions targeting high-volume prescribers of drugs that can harm patients. We take a continuous improvement approach, rapidly evaluating each round and using the results to inform subsequent work. The first round of letters yielded no effects, and we responded with new interventions that are now under evaluation. We discuss lessons our work provides for future government-academic partnerships.

DOI

10.1257/aer.p20171061

Volume

107 (5)

Pages

466-470

Language

en

Export

BibTeX

Sources

openalex crossref